Presence of an inhibitor of glycosyltransferase activity in a patient following an ABO incompatible liver transplant
- 1 May 1988
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 69 (1) , 93-96
- https://doi.org/10.1111/j.1365-2141.1988.tb07608.x
Abstract
The contribution of the liver to plasma ABO glycosyltransferase activity has been studied in a group O individual transplanted with a liver from a group B donor. The B transferase activity present in the post-transplantation plasma was negligible. However, a potent B transferase inhibitor, absent from the pretransplantation plasma, was present after transplantation. The inhibitor was present in the excluded fraction following Sephadex G-25 gel filtration, but was retained by a protein A-Sepharose column, suggesting that it was an IgG antibody. This inhibitor was also effective in reducing A transferase activity.This publication has 6 references indexed in Scilit:
- Plasma blood group glycosyltransferase activities after bone marrow transplantationBlood, 1980
- BIOSYNTHESIS OF ABH AND LEWIS ANTIGENS IN NORMAL AND TRANSPLANTED KIDNEYSTransplantation, 1980
- PLASMA BLOOD-GROUP GLYCOSYLTRANSFERASE ACTIVITIES AFTER BONE-MARROW TRANSPLANTATION1980
- Immunologic homology of human blood group glycosyltransferases and genetic background of blood group (ABO) determinationBlood, 1979
- IMMUNOLOGICAL HOMOLOGY OF HUMAN-BLOOD GROUP GLYCOSYLTRANSFERASES AND GENETIC BACKGROUND OF BLOOD-GROUP (ABO) DETERMINATION1979
- Human blood group glycosyltransferases. I. Purification of n-acetylgalactosaminyltransferase.Journal of Biological Chemistry, 1978